28491000087107: FLUCELVAX QUAD 15 micrograms per 0.5 milliliter suspension for injection Seqirus UK Limited (real clinical drug)

SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...

\Vaccine product\Virus antigen-containing vaccine product\Vaccine product containing Influenza virus antigen (medicinal product)\Inf influenza unspecified\...

\Vaccine product containing only non-live Influenza virus antigen (medicinal product)\Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form)\Inf FLUCELVAX QUAD SEQ

\Vaccine product containing only Influenza virus antigen in parenteral dose form\Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form)\Inf FLUCELVAX QUAD SEQ

\Vaccine product containing only Influenza virus 4 strains antigens (medicinal product)\Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product)\Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form)\Inf FLUCELVAX QUAD SEQ

\Product manufactured as parenteral dose form (product)\Vaccine product containing only Influenza virus antigen in parenteral dose form\Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form)\Inf FLUCELVAX QUAD SEQ

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2021. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Inf FLUCELVAX QUAD SEQ	est un(e) (attribut)	Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form)	true	Inferred relationship	Some
Inf FLUCELVAX QUAD SEQ	Has ingredient characteristic (attribute)	Standard dose (qualifier value)	false	Inferred relationship	Some	4
Inf FLUCELVAX QUAD SEQ	a une forme pharmaceutique (attribut)	forme pharmaceutique pour usage parentéral (forme pharmaceutique)	true	Inferred relationship	Some
Inf FLUCELVAX QUAD SEQ	a pour principe actif (attribut)	Antigen of Influenza A virus subtype H3N2 surface protein (substance)	true	Inferred relationship	Some	2
Inf FLUCELVAX QUAD SEQ	Has product characteristic	Unadjuvanted vaccine product (qualifier value)	true	Inferred relationship	Some
Inf FLUCELVAX QUAD SEQ	Has ingredient characteristic (attribute)	Standard dose (qualifier value)	false	Inferred relationship	Some	2
Inf FLUCELVAX QUAD SEQ	a pour principe actif (attribut)	Antigen of Influenza A virus subtype H1N1 surface protein (substance)	true	Inferred relationship	Some	1
Inf FLUCELVAX QUAD SEQ	Plays role	Active immunity stimulant role (role)	true	Inferred relationship	Some
Inf FLUCELVAX QUAD SEQ	a pour principe actif (attribut)	Antigen of Influenza B virus Victoria lineage surface protein (substance)	true	Inferred relationship	Some	3
Inf FLUCELVAX QUAD SEQ	Has ingredient characteristic (attribute)	Standard dose (qualifier value)	false	Inferred relationship	Some	3
Inf FLUCELVAX QUAD SEQ	Count of base of active ingredient	un	false	Inferred relationship	Some
Inf FLUCELVAX QUAD SEQ	a pour principe actif (attribut)	Antigen of Influenza B virus Yamagata lineage surface protein (substance)	true	Inferred relationship	Some	4
Inf FLUCELVAX QUAD SEQ	Has ingredient characteristic (attribute)	Standard dose (qualifier value)	false	Inferred relationship	Some	1
Inf FLUCELVAX QUAD SEQ	Has supplier	Seqirus UK Limited (supplier)	true	Inferred relationship	Some
Inf FLUCELVAX QUAD SEQ	Count of active ingredient	quatre	false	Inferred relationship	Some
Inf FLUCELVAX QUAD SEQ	Has ingredient qualitative strength	Standard dose (qualifier value)	true	Inferred relationship	Some	4
Inf FLUCELVAX QUAD SEQ	Has ingredient qualitative strength	Standard dose (qualifier value)	true	Inferred relationship	Some	1
Inf FLUCELVAX QUAD SEQ	Has ingredient qualitative strength	Standard dose (qualifier value)	true	Inferred relationship	Some	3
Inf FLUCELVAX QUAD SEQ	Has ingredient qualitative strength	Standard dose (qualifier value)	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Administered tradename codes for vaccines reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
145741000087110	FLUCELVAX QUAD 15 micrograms per 0.5 milliliter suspension for injection Seqirus UK Limited	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
145751000087113	Inf FLUCELVAX QUAD SEQ	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
149711000087111	FLUCELVAX QUAD 15 micrograms per 0.5 milliliter suspension for injection Seqirus UK Limited (real clinical drug)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)